Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to ABEO. [ FAQ on what and how to ask] For non-ABEO questions, click the logo in the upper-right corner to return to the main page and ask there.
Unlock YouTube Video by Subscribing to iPick.ai Premium!
Not available
Address: 6555 Carnegie Avenue, 4th Floor, Cleveland, OH, United States, 44103
Employees: 226
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
President, CEO & Director
Chief Financial Officer
Chief Legal Officer
Chief Technical & Scientific Officer
Vice President of Investor Relations & Corporate Communications
Senior VP & Chief People Officer
VP & Head of Quality
SVP, Chief Commercial Officer & Head of Business Development
Senior Vice President of Regulatory Affairs
Vice President & Head of Quality
My Watchlist
